BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 10707795)

  • 1. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma.
    Chesi M; Kuehl WM; Bergsagel PL
    Ann Oncol; 2000; 11 Suppl 1():131-5. PubMed ID: 10707795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.
    Bergsagel PL; Chesi M; Nardini E; Brents LA; Kirby SL; Kuehl WM
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13931-6. PubMed ID: 8943038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.
    Bergsagel PL; Nardini E; Brents L; Chesi M; Kuehl WM
    Curr Top Microbiol Immunol; 1997; 224():283-7. PubMed ID: 9308253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Close relation between 14q32/IGH translocations and chromosome 13 abnormalities in multiple myeloma: a high incidence of 11q13/CCND1 and 16q23/MAF.
    Takimoto M; Ogawa K; Kato Y; Saito T; Suzuki T; Irei M; Shibuya Y; Suzuki Y; Kato M; Inoue Y; Takahashi M; Sugimori H; Miura I
    Int J Hematol; 2008 Apr; 87(3):260-5. PubMed ID: 18274833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
    Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
    Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
    Avet-Loiseau H; Brigaudeau C; Morineau N; Talmant P; Laï JL; Daviet A; Li JY; Praloran V; Rapp MJ; Harousseau JL; Facon T; Bataille R
    Genes Chromosomes Cancer; 1999 Jan; 24(1):9-15. PubMed ID: 9892103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.
    Richelda R; Ronchetti D; Baldini L; Cro L; Viggiano L; Marzella R; Rocchi M; Otsuki T; Lombardi L; Maiolo AT; Neri A
    Blood; 1997 Nov; 90(10):4062-70. PubMed ID: 9354676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
    Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
    Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.
    Kuipers J; Vaandrager JW; Weghuis DO; Pearson PL; Scheres J; Lokhorst HM; Clevers H; Bast BJ
    Cancer Genet Cytogenet; 1999 Mar; 109(2):99-107. PubMed ID: 10087940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical roles for immunoglobulin translocations and cyclin D dysregulation in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Immunol Rev; 2003 Aug; 194():96-104. PubMed ID: 12846810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.
    Chesi M; Bergsagel PL; Shonukan OO; Martelli ML; Brents LA; Chen T; Schröck E; Ried T; Kuehl WM
    Blood; 1998 Jun; 91(12):4457-63. PubMed ID: 9616139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival.
    Ho PJ; Brown RD; Pelka GJ; Basten A; Gibson J; Joshua DE
    Blood; 2001 Jan; 97(2):490-5. PubMed ID: 11154227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
    Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
    Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
    Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
    Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.